av/alembic--big.svg

COM:ALEMBICPHARMACEUTICALS

Alembic Pharmaceuticals

  • Stock

Last Close

1,123.85

05/11 09:59

Market Cap

196.41B

Beta: -

Volume Today

55.68K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
18.20B
-
20.10B
10.43%
30.55B
51.99%
30.30B
0.82%
30.35B
0.16%
38.07B
25.42%
44.92B
18.00%
52.76B
17.46%
52.32B
0.84%
56.53B
8.04%
62.29B
10.19%
cost of revenue
7.59B
-
7.58B
0.12%
8.43B
11.12%
10.37B
23.11%
10.62B
2.40%
11.93B
12.36%
13.14B
10.12%
15.21B
15.76%
17.23B
13.27%
17.09B
0.83%
34.34B
100.96%
gross profit
10.61B
-
12.52B
17.98%
22.12B
76.75%
19.93B
9.93%
19.73B
1.00%
26.13B
32.46%
31.78B
21.61%
37.55B
18.16%
35.09B
6.56%
39.44B
12.40%
27.95B
29.14%
selling and marketing expenses
1.94B
-
2.45B
26.11%
2.74B
11.85%
3.93B
43.65%
3.80B
3.28%
5.90B
55.18%
5.31B
9.97%
6.96B
31.07%
8.90B
27.88%
9.52B
6.95%
general and administrative expenses
331.94M
-
423.50M
27.59%
517.36M
22.16%
1.45B
180.02%
1.10B
23.93%
1.35B
22.57%
1.55B
14.84%
2.09B
34.52%
2.11B
1.11%
2.41B
14.25%
selling general and administrative expenses
2.27B
-
2.87B
26.32%
3.25B
13.37%
5.38B
65.33%
4.90B
8.84%
7.25B
47.85%
6.86B
5.35%
9.05B
31.85%
11.01B
21.71%
11.93B
8.35%
21.34B
78.82%
research and development expenses
1.16B
-
1.22B
4.46%
3.07B
152.47%
982M
68.02%
368.60M
62.46%
302.70M
17.88%
426.40M
40.87%
253.80M
40.48%
505.90M
99.33%
290.70M
42.54%
other expenses
10.04M
-
17.32M
72.48%
6.74B
38,800.17%
2.50M
99.96%
300K
88%
2.30M
666.67%
200K
91.30%
2M
900%
1.30M
35%
27.40M
2,007.69%
cost and expenses
14.99B
-
16.57B
10.52%
21.19B
27.91%
24.91B
17.54%
25.25B
1.38%
30.49B
20.75%
33.81B
10.88%
39.79B
17.70%
46.39B
16.58%
52.20B
12.51%
55.68B
6.67%
operating expenses
7.40B
-
8.99B
21.43%
12.77B
42.08%
14.54B
13.86%
14.63B
0.65%
18.56B
26.84%
20.67B
11.37%
24.58B
18.93%
29.16B
18.63%
35.11B
20.40%
21.34B
39.22%
interest expense
104.00M
-
38.08M
63.39%
42.73M
12.22%
51.20M
19.82%
34M
33.59%
184.10M
441.47%
271.60M
47.53%
160.20M
41.02%
177.30M
10.67%
501.70M
182.97%
561.90M
12.00%
ebitda
3.59B
-
4.07B
13.22%
10.11B
148.39%
6.14B
39.26%
6.45B
5.02%
8.95B
38.86%
12.25B
36.84%
15.59B
27.32%
9.26B
40.65%
6.80B
26.51%
9.33B
37.22%
operating income
3.21B
-
3.53B
10.03%
9.36B
164.95%
5.39B
42.38%
5.10B
5.44%
7.41B
45.40%
11.11B
49.92%
12.97B
16.68%
5.87B
54.70%
4.38B
25.48%
6.61B
50.92%
depreciation and amortization
404.87M
-
444.13M
9.70%
722.14M
62.60%
829.70M
14.90%
1.05B
27.11%
1.15B
9.26%
1.57B
36.53%
1.83B
16.62%
2.87B
56.31%
2.75B
3.96%
2.73B
1.00%
total other income expenses net
-103.67M
-
58.86M
156.78%
-1.48M
102.52%
-138.40M
9,238.73%
314.20M
327.02%
-12.80M
104.07%
-1.12B
8,613.28%
1.03B
192.33%
379.30M
63.17%
-831.80M
319.30%
-278.80M
66.48%
income before tax
3.11B
-
3.59B
15.60%
9.36B
160.56%
5.25B
43.85%
5.41B
3.03%
7.49B
38.44%
10.00B
33.43%
13.68B
36.83%
6.20B
54.67%
3.55B
42.82%
6.33B
78.46%
income tax expense
751.03M
-
763.49M
1.66%
2.16B
182.93%
1.22B
43.43%
1.20B
1.51%
1.57B
30.25%
1.99B
27.07%
2.53B
27.18%
1.04B
58.76%
126.10M
87.93%
160M
26.88%
net income
2.36B
-
2.83B
20.13%
7.19B
154.29%
4.03B
43.96%
4.13B
2.35%
5.84B
41.62%
8.29B
41.83%
11.46B
38.33%
5.21B
54.56%
3.42B
34.35%
6.16B
80.07%
weighted average shs out
188.56M
-
188.49M
0.04%
188.52M
0.01%
188.52M
0%
188.52M
0%
188.52M
0%
188.52M
0%
193.74M
2.77%
196.56M
1.46%
196.56M
0%
weighted average shs out dil
188.56M
-
188.49M
0.04%
188.52M
0.01%
188.52M
0%
188.52M
0%
188.52M
0%
188.52M
0%
193.74M
2.77%
196.56M
1.46%
196.56M
0%
eps
12.49
-
15.01
20.18%
38.19
154.43%
21.39
43.99%
21.89
2.34%
31
41.62%
43.97
41.84%
59.18
34.59%
26.50
55.22%
17.40
34.34%
31.33
80.06%
epsdiluted
12.49
-
15.01
20.18%
38.19
154.43%
21.39
43.99%
21.89
2.34%
31
41.62%
43.97
41.84%
59.18
34.59%
26.50
55.22%
17.40
34.34%
31.33
80.06%

All numbers in (except ratios and percentages)